Skip To Navigation Skip To Content Skip To Footer
    Advocacy Letter
    Home > Press Statements & Advocacy Letters > Advocacy Letters

    January 8, 2026

     

    The Honorable Morgan Griffith
    Chairman
    Committee on Energy and Commerce, Subcommittee on Health
    U.S. House of Representatives
    2125 Rayburn House Office Building
    Washington, DC 20515

     

    The Honorable Diana DeGette
    Ranking Member
    Committee on Energy and Commerce, Subcommittee on Health
    U.S. House of Representatives
    2125 Rayburn House Office Building
    Washington, DC 20515

       

    Dear Chairman Griffith and Ranking Member DeGette,


    The Medical Group Management Association (MGMA) thanks you for holding today’s legislative hearing, “Legislative Proposals to Support Patient Access to Medicare Services,” to focus on modernizing and strengthening the Medicare program to sustain and enhance seniors’ access to care. With a membership of more than 60,000 medical practice administrators, executives, and leaders, MGMA represents more than 15,000 medical group practices ranging from small private medical practices to large national health systems, representing more than 350,000 physicians.


    We appreciate the Subcommittee’s inclusion of H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025, in today’s hearing. Physician practice laboratories play a critical role in patient care by enabling same-day testing and rapid clinical decision making, which can prevent hospitalizations, reduce costs, and improve outcomes, especially for elderly and rural patients who face barriers to accessing laboratories. For years, MGMA has advocated for improvements to Medicare’s payment system for clinical diagnostic laboratory services to ensure seniors maintain access to essential tests. The RESULTS Act addresses long-standing issues stemming from the Protecting Access to Medicare Act (PAMA) of 2014. While PAMA aimed to align Medicare lab payments with commercial market rates, flaws in its data collection process led to deeper-than-expected cuts, straining laboratories nationwide. Without congressional action, another reduction of up to 15% will take effect on February 1, 2026. The RESULTS Act would strengthen the data used to set sustainable rates under the Medicare Clinical Laboratory Fee Schedule, protecting access to testing and supporting laboratory infrastructure and innovation.

    View the full letter


    More Advocacy Letters

    An error has occurred. The page may no longer respond until reloaded. An unhandled exception has occurred. See browser dev tools for details. Reload 🗙